Market Cap ₹72 Cr.
Stock P/E 30.5
P/B 2.8
Current Price ₹71.2
Book Value ₹ 25
Face Value 10
52W High ₹114.4
Dividend Yield 0%
52W Low ₹ 35.1
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|---|---|
Net Sales | 12 | 11 | 12 | 14 | 14 | 15 | 17 |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Income | 12 | 11 | 12 | 14 | 14 | 15 | 17 |
Total Expenditure | 10 | 11 | 11 | 12 | 13 | 14 | 15 |
Operating Profit | 1 | 1 | 1 | 2 | 1 | 1 | 2 |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 1 | 1 | 1 | 1 | 1 | 0 | 1 |
Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Tax | 1 | 0 | 0 | 1 | 1 | 0 | 1 |
Adjustments | -0 | -0 | 0 | -0 | -0 | -0 | 0 |
Profit After Adjustments | 1 | 0 | 0 | 1 | 1 | 0 | 1 |
Adjusted Earnings Per Share | 0.8 | 0.4 | 0.3 | 0.9 | 0.6 | 0.1 | 0.7 |
#(Fig in Cr.) | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|
Net Sales | 18 | 45 | 40 | 36 | 42 | 49 | 60 |
Other Income | 1 | 0 | 0 | 0 | 1 | 0 | 0 |
Total Income | 18 | 45 | 40 | 36 | 42 | 49 | 60 |
Total Expenditure | 15 | 35 | 34 | 33 | 37 | 44 | 54 |
Operating Profit | 3 | 11 | 6 | 3 | 5 | 5 | 6 |
Interest | 1 | 1 | 0 | 0 | 1 | 0 | 0 |
Depreciation | 1 | 2 | 2 | 1 | 1 | 1 | 1 |
Exceptional Income / Expenses | 0 | -0 | -0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 2 | 8 | 4 | 2 | 3 | 3 | 3 |
Provision for Tax | 1 | 2 | 2 | 0 | 1 | 1 | 0 |
Profit After Tax | 1 | 6 | 2 | 1 | 2 | 2 | 3 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 1 | 6 | 2 | 1 | 2 | 3 | 3 |
Adjusted Earnings Per Share | 1 | 5.6 | 2.2 | 3.7 | 2.3 | 2.6 | 2.3 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 17% | 7% | 22% | 0% |
Operating Profit CAGR | 0% | -6% | 11% | 0% |
PAT CAGR | 0% | 0% | 15% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 75% | 63% | 14% | NA% |
ROE Average | 11% | 9% | 17% | 16% |
ROCE Average | 14% | 14% | 22% | 21% |
#(Fig in Cr.) | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|
Shareholder's Funds | 10 | 15 | 18 | 19 | 21 | 24 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 3 | 2 | 1 | 1 | 1 | 2 |
Other Non-Current Liabilities | -0 | -0 | -0 | 0 | 0 | 0 |
Total Current Liabilities | 7 | 8 | 7 | 8 | 5 | 11 |
Total Liabilities | 20 | 25 | 26 | 28 | 27 | 38 |
Fixed Assets | 4 | 3 | 3 | 2 | 2 | 3 |
Other Non-Current Assets | 2 | 2 | 2 | 2 | 3 | 6 |
Total Current Assets | 14 | 20 | 21 | 24 | 22 | 29 |
Total Assets | 20 | 25 | 26 | 28 | 27 | 38 |
#(Fig in Cr.) | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 1 | 4 | 6 | 7 | 8 | 7 |
Cash Flow from Operating Activities | 2 | 4 | 4 | 2 | 1 | 1 |
Cash Flow from Investing Activities | -5 | -2 | -1 | -1 | -1 | -5 |
Cash Flow from Financing Activities | 6 | -1 | -2 | -0 | -1 | 2 |
Net Cash Inflow / Outflow | 3 | 2 | 1 | 1 | -1 | -2 |
Closing Cash & Cash Equivalent | 4 | 6 | 7 | 8 | 7 | 5 |
# | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 1.05 | 5.56 | 2.19 | 3.65 | 2.26 | 2.56 |
CEPS(Rs) | 1.98 | 7.76 | 3.8 | 6.96 | 3.1 | 3.69 |
DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 9.4 | 14.93 | 17.32 | 55.6 | 20.79 | 23.35 |
Core EBITDA Margin(%) | 15.21 | 23.07 | 13.97 | 8.21 | 10.05 | 9.77 |
EBIT Margin(%) | 12.91 | 18.72 | 10.47 | 5.85 | 9.1 | 7.67 |
Pre Tax Margin(%) | 9.39 | 17.51 | 9.28 | 4.49 | 7.77 | 6.99 |
PAT Margin (%) | 6 | 12.46 | 5.42 | 3.17 | 5.05 | 4.93 |
Cash Profit Margin (%) | 11.37 | 17.5 | 9.64 | 6.53 | 7.58 | 7.68 |
ROA(%) | 5.29 | 24.7 | 8.41 | 4.21 | 7.6 | 7.41 |
ROE(%) | 11.13 | 45.44 | 13.25 | 6.29 | 10.51 | 10.72 |
ROCE(%) | 14.72 | 49.3 | 20.41 | 9.49 | 17.2 | 13.95 |
Receivable days | 127.41 | 54.83 | 69.72 | 91.63 | 88.06 | 105.48 |
Inventory Days | 0 | 0 | 0 | 0 | 0 | 0 |
Payable days | 0 | 0 | 0 | 0 | 0 | 0 |
PER(x) | 24.23 | 6.12 | 8.95 | 3.73 | 22.31 | 15.22 |
Price/Book(x) | 2.7 | 2.28 | 1.13 | 0.24 | 2.42 | 1.67 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 1.56 | 0.71 | 0.45 | 0.25 | 1.08 | 0.88 |
EV/Core EBITDA(x) | 8.53 | 3 | 3 | 2.69 | 9.25 | 8.42 |
Net Sales Growth(%) | 0 | 154.43 | -11.18 | -9.71 | 15.14 | 17.25 |
EBIT Growth(%) | 0 | 268.98 | -50.33 | -49.52 | 79.09 | -1.25 |
PAT Growth(%) | 0 | 428.71 | -61.36 | -47.25 | 83.36 | 14.5 |
EPS Growth(%) | 0 | 431.33 | -60.58 | 66.71 | -38.18 | 13.51 |
Debt/Equity(x) | 0.63 | 0.23 | 0.27 | 0.18 | 0.03 | 0.34 |
Current Ratio(x) | 2.01 | 2.51 | 2.91 | 2.94 | 4.44 | 2.53 |
Quick Ratio(x) | 2.01 | 2.51 | 2.91 | 2.94 | 4.44 | 2.53 |
Interest Cover(x) | 3.67 | 15.45 | 8.81 | 4.3 | 6.82 | 11.4 |
Total Debt/Mcap(x) | 0.23 | 0.1 | 0.24 | 0.25 | 0.01 | 0.2 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 68.7 | 69.67 | 69.67 | 69.67 | 69.86 | 70.1 | 70.8 | 70.8 | 70.8 | 70.8 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0.12 | 0.12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 31.18 | 30.21 | 30.33 | 30.33 | 30.13 | 29.9 | 29.2 | 29.2 | 29.2 | 29.2 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 0.7 | 0.71 | 0.71 | 0.71 | 0.71 | 0.71 | 0.72 | 0.72 | 0.72 | 0.72 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 0.32 | 0.31 | 0.31 | 0.31 | 0.31 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1.02 | 1.02 | 1.02 | 1.02 | 1.02 | 1.02 | 1.02 | 1.02 | 1.02 | 1.02 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About